Filing Flows › Silence Therapeutics (SLN) › Next earnings date
Silence Therapeutics (SLN) earnings on Nov 9, 2026: what to expect
Silence Therapeutics (SLN) is expected to report earnings on Nov 9, 2026 (estimated), tomorrow, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.09 (1 estimate) on revenue of $21K, against −$0.15 and $121K a year ago. It beat the EPS estimate in 50% of the quarters on record; Filing Flows' model gives it a 64% chance of beating next time.
What to watch
Last quarter (Q1 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:
Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS −$0.15 on revenue of $311K, against the analysts' −$0.09.
The last report
Silence Therapeutics reported revenue of $422K for the first quarter 2026 (+197% Y/Y), net loss $15.0M. How it makes money → · Every quarter →
Silence Therapeutics' latest quarter
Silence Therapeutics, Q1 2026: revenue $422K (+197% year over year), net loss $15.0M, operating cash flow −$15.6M. The chart follows the revenue to costs, profit and cash.
Questions
When does SLN report earnings?
Silence Therapeutics is expected to report on Nov 9, 2026 (estimated).
What are analysts expecting from Silence Therapeutics?
EPS of −$0.09 and revenue of $21K for the quarter.
Does Silence Therapeutics usually beat earnings?
It beat the consensus EPS estimate in 50% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.